Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Breast Cancer Research and Treatment

Issue 1/2000

Content (6 Articles)

Chemoprevention of breast cancer

Powel H. Brown, Scott M. Lippman

Management of familial breast cancer risk

Pamela J. Goodwin

Steroid hormone activity of flavonoids and related compounds

Rachel S. Rosenberg Zand, David J.A. Jenkins, Eleftherios P. Diamandis

Ras activation in human breast cancer

Friederike C. von Lintig, Anna D. Dreilinger, Nissi M. Varki, Anne M. Wallace, Darren E. Casteel, Gerry R. Boss

The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis

Adri C. Voogd, Jan-Willem W. Coebergh, Ocker J. Repelaer van Driel, Rudi M.H. Roumen, Mike W.P.M. van Beek, Art Vreugdenhil, Mariad A. Crommelin

What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement

Xianglin Du, Daniel H. Freeman Jr, Dorothy A. Syblik

Jul 00
Issue: 2/2000
Aug 00
Issue: 3/2000

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits